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Abstract
Suicide is one of the leading causes of death in the United States (Centers for Disease
Control and Prevention [CDC], 2017). The Coronavirus Disease 2019 (COVID-19) pandemic
has increased concerns related to suicide, with additional attention placed on the potential longterm negative impact of COVID-19 on mental health. Pharmacists are healthcare providers who
are readily accessible and underutilized in suicide prevention efforts. This study uses survey
methodology and comparative analyses to develop recommendations for the timing and
administration of Question, Persuade, and Refer (QPR) suicide prevention training in the Doctor
of Pharmacy (PharmD) curriculum at the University of Kentucky College of Pharmacy (UK
COP). The findings indicate that QPR suicide prevention training should be administered in the
first and third years of pharmacy school, with a supplemental lesson in the third year on
medications commonly associated with suicide attempts.

3

TABLE OF CONTENTS
EXECUTIVE SUMMARY ...........................................................................................................4
INTRODUCTION..........................................................................................................................5
IMPACT OF THE COVID-19 PANDEMIC ON MENTAL HEALTH ......................................................... 5
LONG-TERM MENTAL HEALTH IMPACT OF PANDEMICS ................................................................. 6
PHARMACIST’S ROLE IN SUICIDE PREVENTION ................................................................................ 7

PROBLEM STATEMENT/HYPOTHESIS ................................................................................7
LITERATURE REVIEW .............................................................................................................8
STATE REQUIREMENTS FOR SUICIDE PREVENTION TRAINING ..................................................... 8
SUICIDE PREVENTION TRAINING PROGRAMS IN COLLEGES OF PHARMACY ............................ 9

DATA PLAN ................................................................................................................................10
RESEARCH DESIGN .................................................................................................................11
RESULTS .....................................................................................................................................14
DEMOGRAPHICS OF PARTICIPANTS .................................................................................................... 14
COMPARISON OF PY1-2016 AND PY-2019 SURVEY DATA ............................................................... 15
ANALYSIS OF PY3-2019 DATA ................................................................................................................ 16

DISCUSSION ...............................................................................................................................17
LIMITATIONS ............................................................................................................................................. 18

CONCLUSIONS & POLICY RECOMMENDATIONS .........................................................19
RECOMMENDATION #1............................................................................................................................ 19
RECOMMENDATION #2............................................................................................................................ 19
RECOMMENDATION #3............................................................................................................................ 19

REFERENCES.............................................................................................................................21
APPENDIX A ...............................................................................................................................24
APPENDIX B ...............................................................................................................................26

4
Executive Summary
QPR Gatekeeper Training for Suicide Prevention is a training program developed by the
QPR Institute that aims to “reduce suicidal behaviors and save lives by providing innovative,
practical, and proven suicide prevention training” (QPR Institute, n.d.). Components of the
course include how to question, persuade, and refer someone who may be suicidal; common
causes of suicidal behavior; warning signs of suicide; and how to help someone in crisis (QPR
Institute, n.d.). Pharmacists are in position to utilize QPR to assist patients at risk for suicide, as
they are among the most accessible and trusted healthcare providers (Reinhart, 2020). Two
separate classes of PharmD students at UK COP have received QPR suicide prevention training
in last five years, once in the First Professional Year (PY1) and once in the Third Professional
Year (PY3).
Previous studies on suicide prevention training in schools of pharmacy have focused on
the impact of a one-time training on PY1 students’ confidence and knowledge when discussing
suicide with patients. The current study used survey methodology to compare PY1 and PY3
student opinions on the role of the pharmacist in suicide prevention and the utility of suicide
prevention training, to determine if and when suicide prevention training should be required in
the UK COP PharmD curriculum. The results of this study indicate that regardless of class year,
students agree that pharmacists have a role in suicide prevention and suicide prevention training
should be provided in pharmacy school. However, PY3 students may receive the most benefit, as
they are more likely to report that they will use the QPR technique in their professional lives.
The majority of PY3 students also indicated they would be interested in a refresher course, which
opens the possibility of providing QPR training twice in the curriculum. Overall, the results
indicate that QPR suicide prevention training is a tool that the majority of students believe they
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will use in their personal and professional lives. The provision of QPR suicide prevention
training is especially important given the rise in patients with mental and emotional health needs
during the COVID-19 pandemic (Gionfriddo, 2020).
Introduction
In the years leading up to the COVID-19 pandemic, suicide was the tenth leading cause
of death in the United States (CDC, 2017). Suicide mortality rates had been rising for almost
every age group in the United States, with a widening gap in rates between rural and urban
counties (Hedegaard et al., 2020). For every death by suicide, there were 29 suicide attempts.
The WHO has recognized suicide as a public health concern.
Impact of the COVID-19 pandemic on mental health
The COVID-19 pandemic has increased concerns related to mental health, suicide, and
the accessibility of mental health resources and treatment. Mental Health America released data
indicating a significant increase in utilization of their online anxiety and depression screening
tools during the pandemic. There have been more positive anxiety and depression screens, in
addition to higher numbers of individuals reporting thoughts of suicide or self-harm (Gionfriddo,
2020). Primary care clinicians are also observing an increase in the number of patients with
mental or emotional health needs (Primary Care Collaborative [PCC], 2020). The most
commonly cited reason for mental health problems in the general population is
loneliness/isolation (Gionfriddo, 2020). Given that the perception of loneliness is strongly
associated with suicidal ideation and parasuicide (deliberate self-harm not intended to cause
death), adequate access to mental health resources is necessary (Strayvnksi & Boyer, 2001).
However, patients may have a harder time accessing their primary care clinicians due to lack of
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access to telehealth, redeployment of providers to different roles, and an increase in practice time
allocated to COVID-19 screenings (PCC, 2020).
As the number of individuals with mental and emotional health needs has increased, there
has been a subsequent increase in the number of anxiolytic, antidepressant, and hypnotic
medication therapies prescribed by doctors (Luddy, 2020). This is notable, given that all three of
these classes of medications were commonly identified on toxicology reports in a study of
individuals who had died by suicide, specifically by means of overdose (Sinyor et al, 2012). In
Kentucky, pharmacists are required to offer patients medication counseling for all new
prescriptions. Knowledge of the medications most often used in suicide attempts may assist
pharmacists in identifying patients who are at higher risk of suicide by overdose. Additional time
can be dedicated to counseling patients on these medications and having open discussions about
suicidal ideation.
Long-term mental health impact of pandemics
While the long-term impact of the COVID-19 pandemic on mental health has yet to be
determined, past research on infectious diseases, including Middle East Respiratory Syndrome
and Severe Acute Respiratory Syndrome, suggest that social isolation and quarantine are
associated with a sustained negative impact on mental health in the general population (Jeong et
al., 2016; Wu et al., 2009). Feelings of anxiety and anger can persist for months following
isolation, especially in individuals with a history of mental illness (Jeong et al., 2016).
Healthcare workers are at risk for post-traumatic stress disorder, depression, and alcohol abuse or
dependency, indicating that it is important for healthcare workers to consider their colleagues’
mental health in addition to their patients’ (Wu et al., 2009; Brooks et al., 2020).
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Pharmacists’ role in suicide prevention
Pharmacists have an opportunity to play a key role in suicide prevention given that they
are among the most accessible and trusted healthcare providers (Reinhart, 2020). Pharmacists in
both the community and hospital settings can be utilized to identify patients and colleagues who
display risk factors for suicide. Given the historical upward trend in suicide rates and the
potential long-term impact of COVID-19 on mental health, it is imperative that pharmacists
embrace their role in suicide prevention; however, education and training is needed (Hedegaard
et al., 2020). Pharmacists report poor suicide intervention skills and lack of experience in
assisting patients contemplating suicide, especially in comparison to other community
professionals (Scheerder et al., 2012). Currently, the only state that requires suicide prevention
training is Washington, although some schools of pharmacy across the nation have started
providing suicide prevention training (Carpenter et al., 2018; Willson et al., 2020; Witry et al.,
2019). Overall, more widespread training is needed to improve pharmacy students’ and
pharmacists’ skills in suicide prevention.
Problem Statement/Hypothesis
PharmD students at UK COP have intermittently participated in suicide prevention
training, but there is no formal requirement for students to receive suicide prevention training
prior to graduation. QPR suicide prevention training has been administered twice in the past five
years at the discretion of course coordinators. The first offering was in April 2016, when First
Professional Year (PY1) students received training as part of the class titled “PHR 920:
Communication and Behavior in Pharmacy Practice,” a course that was phased out with
curricular reform in August 2016. The second QPR suicide prevention training offering occurred
in August 2019, when Third Professional Year (PY3) students received training as part of the
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class titled “PHR 956: Integrated Drugs and Diseases: Psychiatry.” Components of the training
sessions included background and statistical information on suicide, suicide myths and
misconceptions, identifying individuals at risk for suicide, how to communicate about suicide,
and referral resources (Carpenter et al., 2018). I aim to understand if the timing of suicide
prevention training in the PharmD curriculum impacts student opinions regarding the utility of
training. PY3 students have more clinical knowledge and have had more interactions with
patients through experiential education and internships, which improves understanding of the
role and capabilities of pharmacists in providing patient care. Therefore, PY3 students previously
enrolled in “PHR 956: Integrated Drugs and Diseases: Psychiatry,” are likely to have more
positive responses regarding the administration of suicide prevention training in pharmacy
school and the role of pharmacists in suicide prevention, compared to PY1 students previously
enrolled in “PHR 920: Communication and Behavior in Pharmacy Practice.”
Literature Review
State requirements for suicide prevention training
Washington is the only state that requires pharmacists to participate in suicide prevention
training (Carpenter et al., 2018). The Matt Adler Suicide Prevention, Treatment, and
Management Training Act of 2012 requires that pharmacists receive a one-time, three-hour
training course during the first continuing education reporting period following licensure
(Washington State Legislature, 2012). The bill encountered objections from healthcare providers,
including concerns regarding cost of training and time commitment (Stuber & Quinnett, 2013).
Proponents of the bill hypothesized that there may be less resistance to passage of similar
legislature in other states if the requirements for training are specific to graduate training
programs rather than licensed healthcare professionals (Stuber & Quinnett, 2013).
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Suicide prevention training programs in colleges of pharmacy
Schools of pharmacy have recently started piloting suicide prevention training programs
despite no formal state requirements for training (Carpenter et al., 2018; Willson et al., 2020;
Witry et al., 2019). The University of Iowa College of Pharmacy administered suicide prevention
training to PY1 students (Witry et al., 2019). The 50-minute session included information on
suicide statistics and public health significance; protective factors, risk factors, and warning signs
for suicidal ideation; strategies for asking about suicidal ideation; resources specific to the local
community; and case scenarios with questions. An optional survey was administered following
the session. The majority of students indicated that they were confident in asking someone if
they are thinking about suicide, however there was no formal assessment to support this
statement. When prompted to provide topics for additional learning, students expressed interest
in more practice, medication-specific knowledge, and learning to intervene in a pharmacy
context (Witry et al., 2019). The feedback from students warrants further investigation into
appropriate suicide prevention training content and timing in the pharmacy curriculum.
Washington State University College of Pharmacy and Pharmaceutical Services also
initiated a suicide prevention training program (Willson et al., 2020). The 3.5-hour training for
PY1 students included an online didactic portion and a laboratory session. Pre- and post-surveys
were administered to gauge students’ knowledge and confidence surrounding discussions on
suicide. Additionally, a laboratory assessment with a standardized patient was performed. Survey
responses indicated that students had increased knowledge and confidence in discussing the topic
of suicide. However, when paired with a standardized patient, they were unable to identify risk
factors for suicide, elicit more information from the patient regarding suicidal ideation, or
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directly ask about suicide (Willson et al., 2020). These results suggest that a one-time training
may not be sufficient to change student behavior.
Data Plan
This study used survey methodology to investigate students’ opinions on incorporating
QPR suicide prevention training into the PharmD curriculum at UK COP. In both student cohorts
(i.e., PY1-2016 students and PY3-2019 students), QPR suicide prevention training was provided
by certified QPR instructors from the University of Kentucky Counseling Center and students
were trained in small groups (~30-35 students per group) in sessions lasting approximately 90
minutes. Attending a QPR session was required for both cohorts, although no course “grade” was
associated with the training. This study compared opinions related to QPR suicide prevention
training between the cohorts to determine if the timing (PY1 versus PY3) of QPR suicide
prevention training in the PharmD curriculum impacts student opinions on the utility of training.
Survey data from the PY1-2016 cohort was previously collected in September 2016,
approximately 5 months after the QPR suicide prevention training session in April 2016. The
survey was designed, disseminated, and collected using the Research Electronic Data Capture
(REDCap) web application hosted by the University of Kentucky. Permission to access the data
from the PY1-2016 survey through REDCap was granted by Dr. Karen Blumenschein, the
course coordinator of “PHR 920: Communication and Behavior in Pharmacy Practice” and coinvestigator of a research project that analyzed the PY1-2016 survey results (Ekinci, 2017). The
data collected from the PY1-2016 cohort was compared to that collected from the PY3-2019
cohort.
To capture the opinions of the PY3-2019 cohort, a 25-item survey (see Appendix A) was
generated using REDCap. The survey was anonymous and did not collect identifying
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information. Questions were designed to assess student pharmacists’ opinions on the role of
pharmacists in suicide prevention, the likelihood of using QPR suicide prevention training in the
future, and the claim that QPR is analogous to cardiopulmonary resuscitation (CPR). Survey
items included demographic, multiple choice, and Likert scale questions that had fixed
responses. Contingency questions followed responses indicating that a student did not believe
they would use QPR suicide prevention training in the future. If a participant selected “other” in
response to a contingency question, they were prompted with a free response text box to provide
an alternative response. One question allowed participants to provide a free response in the form
of suggestions or comments related to the training session.
All 139 PY3-2019 students who participated in QPR suicide prevention training were
invited to participate in the PY3-2019 survey. The survey data was collected in November 2020,
approximately one year after their training session. Students were invited through email to
participate in the survey. In addition to a survey link, the email included a brief description of the
study and informed students that the survey would close in two weeks. One reminder email was
sent one week after the initial email. This project was approved by the University of Kentucky
Institutional Review Board in August 2020 and all students were required to provide informed
consent prior to completing the survey.
Research Design
Survey questions were adapted from the PY1-2016 survey that was designed for a
research project with objectives listed as 1) assess first-year pharmacy student (PY1) opinions
related to a suicide prevention training module and 2) identify PY1 opinions on the pharmacist’s
role in suicide prevention (Ekinci, 2017). All questions with an asterisk (see Appendix A) were
carried over from the PY1-2016 survey. These questions were included to allow for a direct
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comparison between the PY1-2016 and PY3-2019 cohorts regarding opinions of QPR suicide
prevention training and the role of a pharmacist in suicide prevention. The majority of PY1-2016
respondents believed that pharmacists should have a role in suicide prevention, suicide
prevention training should be provided in pharmacy school, and that they would utilize the
training in their personal and professional lives.
Given the positive responses on the prior survey, additional questions were included in
the PY3-2019 survey to capture more information related to utilization of training; perceptions of
CPR training, which is currently required biennially for all students; and the impact of COVID19 on mental health. To determine if there is a benefit in requiring QPR suicide prevention
training prior to students entering pharmacy internships and clinical rotations, students were
asked if they have used CPR and/or QPR since receiving the trainings. Responses to questions
regarding CPR training will provide a better understanding of the analogy between QPR and
CPR, which is presented in QPR suicide prevention training courses. This will indicate whether a
refresher course should be provided in QPR, similar to what is currently required for CPR. It was
also important to collect information regarding perceptions of COVID-19 and mental health
given that the timing of this survey may impact opinions on the utility of suicide prevention
training.
Based on preliminary mental health data collected during the COVID-19 pandemic, it is
likely that the pandemic is negatively impacting the mental health of the general public and
healthcare workers, including pharmacists. There is a set of questions that explicitly asked for
opinions regarding the impact of COVID-19 on the mental health of the general population and
pharmacists. Additionally, there is a set of questions that solicited data regarding the perceived
stress level of pharmacists, which may be influenced by the pandemic. Questions pertaining to
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the perceived stress of pharmacists served a dual purpose of indirectly gauging how the
pandemic has impacted pharmacists’ stress levels and determining if suicide prevention training
may be beneficial to increase awareness of suicide risk factors. Given that results from prior
research suggest that social isolation and quarantine during infectious disease outbreaks are
associated with a sustained negative impact on mental health, it was important to collect
information regarding the anticipated long-term impact of COVID-19 on the mental health of
pharmacists.
The question order and format of the survey was designed intentionally to avoid biasing
participant responses. The survey (see Appendix A) is divided into three sections that can be
summarized as demographics (questions 1-7), CPR/QPR (questions 8-22), and COVID-19
(questions 23-25), with all questions for each individual section appearing on one page.
Participants were not able to navigate backwards to change responses on prior sections.
IBM SPSS version 26 statistical software was used to analyze the survey data. All Likert
scale responses were converted to a numerical value ranging from 1 (definitely not) to 5
(definitely). Fisher’s exact tests were used to compare PY1-2016 and PY3-2019 survey
responses to dichotomous questions, and Mann-Whitney U tests were used to compare responses
to Likert scale questions. The PY3-2019 survey data were analyzed further. Descriptive statistics
were generated for all questions. The Wilcoxon Signed-Rank test was used to determine if there
is a significant change in perceived stress levels from the beginning of pharmacy school to the
time the survey was completed. The Kruskal-Wallis test was used to determine if the pharmacy
setting that a student has the most experience in impacts the perceived stress level of
pharmacists.
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Survey responses and subsequent analyses will help determine if incorporating suicide
prevention training into the UK COP curriculum is beneficial to PharmD students. They will also
indicate if students are interested in receiving additional, pharmacy-specific training beyond the
programming that is currently available to students on campus. This will help shape future
programming to better educate students on suicide prevention. Overall, the survey responses and
analysis will help determine if changes should be made to UK COP graduation requirements to
include QPR suicide prevention training.
Results
Demographics of participants
In total, 67 out of 139 students completed the PY1-2016 survey, for a response rate of
48.2%. Forty-seven out of 138 students completed the PY3-2019 survey, for a response rate of
34.1%. Participant demographics are provided in Table 1. There was no difference in gender or
prior QPR training between survey participants. There were significantly more students in the
PY1-2016 cohort with plans to work in a community pharmacy post-graduation compared to the
PY3-2019 cohort (p = 0.031), but there was no difference in post-graduation plans across other
work settings. The PY3-2019 cohort had the majority of their recent work experience in chain
pharmacies (n=18), independent pharmacies (n=13), academic medical center pharmacies (n=6),
ambulatory care pharmacies (n=4), community hospitals (n=4), and long-term care settings
(n=2).
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PY1
PY3
N (%)
N (%)
45 (67.16) 32 (68.09)

Female sex
Age
18-24
25-30
Over 30
Plans post-graduation (work setting)
Community
Hospital
Long-term care
Setting without patient care
Not reported
Prior QPR training

p value
1.000

46 (86.57) 22 (46.81) -5 (10.45) 22 (46.81) -1 (2.99)
3 (6.38)
-31 (46.27)
28 (41.79)
1 (1.49)
6 (8.96)
1 (1.49)
9 (13.43)

12 (25.53)
29 (61.70)
3 (6.38)
3 (6.38)
0 (0.00)
12 (25.53)

0.031
0.057
0.304
0.734
1.000
0.14

Table 1: Demographics of survey participants

Comparison of PY1-2016 and PY-2019 survey data

Table 2 and Figures 1a-d provide comparisons of PY1-2016 and PY3-2019 survey
responses. There was no difference in student opinions related to a pharmacist’s role in suicide
prevention, suicide prevention training in pharmacy school, or the analogy between CPR and
QPR. Additionally, there was no significant difference in responses regarding the anticipated use
of information from QPR training in students’ personal lives (p = 0.17). However, the PY3-2019
cohort had significantly more positive responses compared to the PY1-2016 cohort when asked
if they anticipated utilizing information from QPR training in their professional lives (p = 0.04).
PY1
N (%)
Q8: Suicide is one of the top-ten leading causes of death in the U.S. Do you think
pharmacists have a role in suicide prevention?
Yes
No
Q9: Do you think suicide prevention training should be provided in pharmacy school?
Yes
No
Q17: QPR has been described as analogous to CPR because both are the initial step in
saving a life. Do you agree or disagree with this analogy?
Yes
No
Table 2: Comparison of PY1-2016 and PY3-2019 survey responses

PY3
N (%)

p value
0.121

58 (86.57) 45 (95.74)
9 (13.43) 2 (4.26)
0.079
59 (88.06) 46 (97.87)
8 (11.94) 1 (2.13)
0.810
54 (80.60) 39 (82.98)
13 (19.40) 8 (17.02)
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Yes,
definitely
No, probably
(n = 7)
not (n = 11)

Yes,
probably
(n = 31)

Not, sure
(n =18)

Figure 1a: PY1 expected use of QPR training in personal life

No, probably Yes,
not (n = 6) definitely
(n = 9)

No, probably
not (n = 3)

Yes,
definitely
(n = 10)

Not, sure
(n = 15)
Yes,
probably
(n = 19)

Figure 1b: PY3 expected use of QPR training in personal life

No, probably
not (n = 3)
Yes,
definitely
(n = 13)

Not sure
(n = 8)

Not sure
(n = 20)
Yes,
probably
(n = 32)

Figure 1c: PY1 expected use of QPR training in professional life

Yes,
probably
(n = 23)

Figure 1d: PY3 expected use of QPR training in professional life

Analysis of PY3-2019 data
To understand how students’ impressions of a pharmacist’s stress level have changed
over time, students were queried on what they believed the stress level of a pharmacist to be
prior to pharmacy school and at the time they were completing the survey. A Wilcoxon SignedRank indicated that the students’ current perceived stress level of pharmacists was statistically
significantly higher than the perceived stress level of pharmacists prior to entering pharmacy
school (Z = -5.11, p = 0.00). However, there is no difference in students’ current perceived
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stress level of pharmacists based on the pharmacy setting in which the student has the most
experience (H(5) = 4.05, p = 0.54). Appendix B includes all descriptive statistics and open
responses for the PY3-2019 survey.
Discussion
There is a lack of pharmacists who are competent in assisting patients experiencing
mental health crises and/or contemplating suicide. Optional Mental Health First Aid and suicide
prevention programs are available to pharmacy students and pharmacists who desire to improve
the mental health of their communities (Carpenter et al, 2018; Witry et al., 2020). Participants
have benefited from these programs through increased knowledge about suicide and increased
confidence to directly ask an individual about suicide and provide resources (Willson et al.,
2020; Witry et al, 2019). However, not all pharmacists are required to receive suicide prevention
training. Dedicating time to suicide prevention training in the pharmacy school curriculum
increases the likelihood that future pharmacists are able to identify and assist individuals at risk
for suicide. Therefore, colleges of pharmacy should consider providing training to students.
UK COP is in a position to equip students with a tool to provide quality, competent care,
while acknowledging the importance of prioritizing mental health. In the past few years UK COP
has focused efforts on respecting and maximizing the well-being of students, which has
increased discussion surrounding mental health. Incorporating QPR suicide prevention training
into the curriculum would promote mental well-being and solidify the commitment to
destigmatizing mental illness. If administered during the first year of school, training may have a
protective effect on the cohort, as students would be able to identify classmates who may be
contemplating suicide. Regardless of when suicide prevention training is administered, there will
be a benefit to the communities that students go on to serve as practicing pharmacists.
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Limitations
This analysis has several limitations. First, there was a difference in the timing of the
surveys post-training. The PY1-2016 survey was dispensed five months after training, while the
PY3-2019 survey was dispensed 15 months after training. This difference in time may have
influenced responses and the response rate. The response rate from the PY3-2019 cohort was
lower than that of the PY1-2016 cohort. Of note, the PY3-2019 cohort was on clinical rotations
and no longer in the classroom at the time they received the survey. Rotation responsibilities may
have impacted their willingness to dedicate time to responding to the survey.
Second, there were already high rates of positive responses in the PY1-2016 cohort to
questions regarding the utility of suicide prevention training in pharmacy school and the role of a
pharmacist in suicide prevention. The PY3-2019 also had a large number of positive responses,
which led to a small number of statistically significant results. While this suggests that students
are receptive to suicide prevention training, it does not help differentiate when training should be
provided.
Finally, this study relied on self-reporting. There was no formal assessment to confirm
the response to the question, “Do you feel comfortable using the QPR technique?” The majority
of students responded that they were comfortable using the technique, but findings from Willson
et al. (2020), suggest that despite reported confidence in using suicide prevention techniques,
students do not utilize the techniques when confronted with a standardized patient. A formal
assessment is needed following QPR suicide prevention training to confirm that students are
comfortable and able to use the QPR technique when confronted with actual patients displaying
risk factors for suicide.
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Conclusions & Policy Recommendations
Recommendation #1: QPR suicide prevention training should be a graduation requirement for
the PharmD program at UK COP.
The majority of PY1 and PY3 students agreed that suicide prevention training should be
provided in pharmacy school and that pharmacists have a role in suicide prevention. This
indicates an understanding of the utility of training and a willingness to intervene using the QPR
technique. Given the rising suicide rates in the United States and the increase in the number of
individuals reporting thoughts of suicide or self-harm during the COVID-19 pandemic, it would
be beneficial to establish QPR suicide prevention training as a graduation requirement
(Gionfriddo, 2020; Hedegaard et al., 2020). This requirement would ensure that students receive
suicide prevention training regardless of changes in course coordinators.
Recommendation #2: QPR suicide prevention training should be administered twice in the
PharmD curriculum, in the fall semesters of PY1 and PY3.
While the majority of the PY3-2019 cohort indicated that they are comfortable using the
QPR technique, a majority also indicated that they are interested in a refresher QPR session. This
information, combined with results reported by Willson et al (2020) indicating that students do
not use the QPR technique in practice, suggests that a one-time training is not sufficient. The
QPR Institute states that QPR certification is active for two years (QPR Institute, n.d.). If QPR
training is provided in PY1, then it can be provided again in PY3 to refresh students’ skills and
to remain consistent with the QPR Institute’s recommendation for re-certification every two
years.
Recommendation #3: During PY3, QPR suicide prevention training should be supplemented with
a session on medications commonly associated with suicide attempts.
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Almost all of the PY3-2019 cohort indicated that they are interested in a supplemental
training session on medications commonly associated with suicide attempts. In the PharmD
curriculum, Integrated Drugs and Diseases classes are those in which students learn about
medications as they relate to disease states. These classes are not introduced until the spring
semester of the first year of pharmacy school, Therefore, if training is provided in the fall
semester of the first year, then it is unlikely that students would benefit from a supplemental
session due to their lack of a general understanding of medications. It would be most beneficial
to incorporate the supplemental training session into the third year of pharmacy school.

21
References
Brooks, S. K., Webster, R. K., Smith, L. E., Woodland, L., Wessely, S., Greenberg, N., & Rubin,
G. J. (2020). The psychological impact of quarantine and how to reduce it: rapid review
of the evidence. The Lancet, 395(10227), 912-920. https://doi.org/10.1016/S01406736(20)30460-8
Carpenter, D. M., Lavigne, J. E., Roberts, C. A., Zacher, J., & Colmenares, E. W. (2018). A
review of suicide prevention programs and training policies for pharmacists. Journal of
the American Pharmacists Association, 58(5), 522-529.
https://doi.org/10.1016/j.japh.2018.05.004
Centers for Disease Control and Prevention. (2017, March 17). Leading causes of death.
https://www.cdc.gov/nchs/fastats/leading-causes-of-death.htm
Cigna. (2016, April 16). America’s state of mind: Use of mental health medications increasing
with spread of coronavirus. https://www.cigna.com/about-us/newsroom/news-andviews/press-releases/2020/americas-state-of-mind-use-of-mental-health-medicationsincreasing-with-spread-of-coronavirus
Ekinci, E. (2017, July). Pharmacy Student Opinions of Suicide Prevention Training. [Poster
Presentation].
Gionfriddo, P. (2020, June). COVID-19 and mental health: what we are learning from
www.mhascreening.org [PowerPoint slides]. Mental Health America. Retrieved from
https://mhanational.org/sites/default/files/Coronavirus%20Mental%20Health%20Present
ation%206-1-2020.pdf
Hedegaard, H., Curtin, S. C., & Warner, M. (2020). Increase in suicide mortality in the United
States, 1999-2018 (Data brief No. 362). National Center for Health Statistics.

22
Jeong, H., Yim, H. W., Song, Y. J., Ki, M., Min, J. A., Cho, J., & Chae, J. H. (2016). Mental
health status of people isolated due to Middle East Respiratory Syndrome. Epidemiology
and Health, 38, e2016048. https://doi.org/10.4178/epih.e2016048
Primary Care Collaborative. (2020, April 9). Primary care & COVID-19: Week 4 survey.
https://www.pcpcc.org/2020/04/08/primary-care-COVID-19-week-4-survey
QPR Institute. (n.d.). What is QPR? https://qprinstitute.com/about-qpr
Reinhart, R. (2020, January 6). Nurses continue to rate highest in honesty, ethics. Gallup.
https://news.gallup.com/poll/274673/nurses-continue-rate-highest-honesty-ethics.aspx
Scheerder, G., Reynders, A., Andriessen, K., & Van Audenhove, C. (2010). Suicide Intervention
Skills and Related Factors in Community and Health Professionals. Suicide and LifeThreatening Behavior, 40(2), 115-124. https://doi.org/10.1521/suli.2010.40.2.115
Sinyor, M., Howlett, A., Cheung, A. H., & Schaffer, A. (2012). Substances Used in Completed
Suicide by Overdose in Toronto: An Observational Study of Coroner’s Data. The
Canadian Journal of Psychiatry, 57(3), 184-191.
https://doi.org/10.1177/070674371205700308
Stravynski, A., & Boyer, R. (2001). Loneliness in relation to suicide ideation and parasuicide: A
population-wide study. Suicide and Life-Threatening Behavior, 31(1), 32-80.
https://doi.org/10.1521/suli.31.1.32.21312
Stuber, J., Quinnett, P. (2013). Making the case for primary care and mandated suicide
prevention education. Suicide and life-threatening behavior, 43(2), 117-124.
https://doi.org/10.1111/sltb.12010
Washington State Legislature. (2012). Matt Adler suicide assessment, treatment, and
management training act of 2012. https://app.leg.wa.gov/rcw/default.aspx?cite.43.70.442.

23

Willson, M. N., Robinson, J. D., McKeirnan, K. C., Akers, J. M., & Buchman, C. R. (2020).
Training Student Pharmacists in Suicide Awareness and Prevention. American Journal of
Pharmaceutical Education, 84(5). https://doi.org/10.5688/ajpe847813
Witry, M., Karamese, H., & Pudlo, A. (2020). Evaluation of participant reluctance, confidence,
and self-reported behaviors since being trained in a pharmacy Mental Health First Aid
initiative. PLoS ONE, 15(5), e0232627. https://doi.org/10.1371/journal.pone.0232627
Witry, M. J., Neblett, K., Hutchens, S., & Catney, C. (2019). When a patient talks about suicide:
Adding a social worker led session on the pharmacist’s role in suicide prevention to the
PharmD curriculum. Currents in Pharmacy Teaching and Learning, 11(6), 585-591.
https://doi.org/10.1016/j.cptl.2019.02.027
Wu, P., Fang, Y., Guan, Z., Fan, B., Kong, J., Yao, Z., Liu, X., Fuller, C. J., Susser, E., Lu, J., &
Hoven, C. W. (2009). The psychological impact of the SARS epidemic on hospital
employees in China: exposure, risk perception, and altruistic acceptance of
risk. Canadian Journal of Psychiatry, 54(5), 302–311.
https://doi.org/10.1177/070674370905400504

24
Appendix A
1. What is your gender?*
2. How old are you?*
3. In what setting do you have the MOST pharmacy experience?
3a. Follow up question: If you chose "Other" please specify:
4. Prior to entering pharmacy school, what did you perceive the stress level of pharmacists
to be?
5. Currently, what do you perceive the stress level of pharmacists to be?
6. If your perception of pharmacists’ stress level has changed, why do you think it has
changed?
7. When you finish your training in pharmacy, where do you anticipate that you will
practice?*
8. Suicide is one of the top-ten leading causes of death in the U.S. Do you think pharmacists
have a role in suicide prevention?*
9. Do you think suicide prevention training should be provided in pharmacy school?*
10. One form of suicide prevention training is QPR (Question, Persuade, Refer). In August
2019 you completed QPR training. Did you ever receive QPR training prior to August
2019?*
11. Do you feel comfortable using the QPR technique?
12. Have you used the QPR technique since receiving QPR training?
12a. Follow up question (if “yes”): In what setting did you use the QPR technique?
13. Do you foresee utilizing the information you learned during the QPR training session in
your PERSONAL LIFE?*
13a. Follow up question (if “no, probably not” or “no, definitely not”): Why not?*
13b. Follow up question: If you chose "Other" as your reason, please specify:*
14. Do you foresee utilizing the information you learned during the QPR training session in
your FUTURE PRACTICE AS A PHARMACIST?*
14a. Follow up question (if “no, probably not” or “no, definitely not”): Why not?*
14b. Follow up question: If you chose "Other" as your reason, please specify:*
15. Would you be interested in a refresher QPR session?
16. Do you believe that you would benefit from a supplemental training session on
medications commonly associated with suicide attempts?
17. QPR has been described as analogous to CPR because both are the initial step in saving a
life. Do you agree or disagree with this analogy?*
18. Do you think CPR should be required in pharmacy school?
19. Have you used CPR since receiving CPR training?
19a. Follow up question (if “yes”): In what setting did you use CPR?
20. CPR training is required for all pharmacy students. Do you think QPR training should
also be required for all pharmacy students?*
21. Recertification in CPR is required every two years. Do you think recertification in QPR
should be required every two years?
22. Do you have any suggestions or comments related to the QPR training session that you
completed in August 2019?*
23. How do you think that quarantine and/or social isolation during the COVID-19 pandemic
has impacted suicidal ideation in the general population?
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23a. Follow up question (if “increase”): Do you foresee that this increase will be
sustained following the lifting of all social distancing restrictions?
23b. Follow up question (if “yes”): How long do you think this increased level
will be sustained?
24. Do you foresee the COVID-19 pandemic having a long-term impact on the mental health
of the GENERAL POPULATION?
25. Do you foresee the COVID-19 pandemic having a long-term impact on the mental health
of PHARMACISTS?
*question asked in PY1-2016 survey
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Appendix B
Column1
N (%)
Q1: What is your gender?
Male
15 (31.91)
Female
32 (68.09)
Other
0 (0.00)
Prefer not to answer
0 (0.00)
Q2: How old are you?
18-24
22 (46.81)
25-30
22 (46.81)
Over 30
3 (6.38)
Q3: In what setting do you have the MOST pharmacy experience?
Chain pharmacy
18 (38.30)
Independent pharmacy
13 (27.66)
Compounding pharmacy
0 (0.00)
Ambulatory care pharmacy
4 (8.51)
Academic medical center
6 (12.77)
Community hospital
4 (8.51)
Long-term care setting
2 (4.26)
Other
0 (0.00)
Q4: Prior to entering pharmacy school, what did you perceive the stress level of pharmacists to be?
High
12 (25.53)
Average
33 (70.21)
Low
2 (4.26)
Q5: Currently, what do you perceive the stress level of pharmacists to be?
High
38 (80.85)
Average
9 (19.15)
Low
0 (0.00)
Q7: When you finish your training in pharmacy, where do you anticipate that you will practice?
Community
12 (25.53)
Hospital
29 (61.70)
Long-term care
3 (6.38)
Setting without patient care
3 (6.38)
Not reported
0 (0.00)
Q8: Suicide is one of the top-ten leading causes of death in the U.S. Do you think pharmacists have a
role in suicide prevention?
Yes
45 (95.74)
No
2 (4.26)
Q9: Do you think suicide prevention training should be provided in pharmacy school?
Yes
46 (97.87)
No
1 (2.13)
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Column1
N (%)
Q10: One form of suicide prevention training is QPR (Question, Persuade, Refer). In August 2019, you
completed QPR training. Did you ever receive QPR training prior to August 2019?
Yes
12 (25.53)
No
35 (74.47)
Q11: Do you feel comfortable using the QPR technique?
Yes
33 (70.21)
No
14 (29.79)
Q12: Have you used the QPR technique since receiving QPR training?
Yes
4 (8.70)
No
42 (91.30)
Q13: Do you foresee utilizing the information you learned during the QPR training session in your
PERSONAL LIFE?
Yes, definitely
10 (21.28)
Yes, probably
19 (40.43)
Not sure
15 (31.91)
No, probably not
3 (6.38)
No, definitely not
0 (0.00)
Q14: Do you foresee utilizing the information you learned during the QPR training session in your
FUTURE PRACTICE AS A PHARMACIST?
Yes, definitely
13 (27.66)
Yes, probably
23 (48.94)
Not sure
8 (17.02)
No, probably not
3 (6.38)
No, definitely not
0 (0.00)
Q15: Would you be interested in a refresher QPR session?
Yes
36 (76.60)
No
11 (23.40)
Q16: Do you believe that you would benefit from a supplemental training session on medications
commonly associated with suicide attempts?
Yes
45 (95.74)
No
2 (4.26)
Q17: QPR has been described as analogous to CPR because both are the initial step in saving a life. Do
you agree or disagree with this analogy?
Yes
39 (82.98)
No
8 (17.02)
Q18: Do you think CPR should be required in pharmacy school?
Yes
47 (100.00)
No
0 (0.00)
Q19: Have you used CPR since receiving CPR training?
Yes
4 (8.51)
No
43 (91.49)
Q20: CPR training is required for all pharmacy students. Do you think QPR training should also be
required for all pharmacy students?
Yes
No

43 (91.49)
4 (8.51)
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Column1
N (%)
Q21: Recertification in CPR is required every two years. Do you think recertification in QPR should be
required every two years?
Yes
No

32 (68.09)
15 (31.91)

Q23a: How do you think that quarantine and/or social isolation during the COVID-19 pandemic has
impacted suicidal ideation in the general population?
Increase
47 (100)
No change
0 (0.00)
Decrease
0 (0.00)
Q23b: Do you foresee that this increase will be sustained following the lifting of all social distancing
restrictions?
Yes
27 (57.45)
No
20 (42.55)
Q24: Do you foresee the COVID-19 pandemic having a long-term impact on the mental health of the
GENERAL POPULATION?
Yes
43 (91.49)
No
4 (8.51)
Q25: Do you foresee the COVID-19 pandemic having a long-term impact on the mental health of
PHARMACISTS?
Yes
41 (87.23)
No
6 (12.77)

Q6: If your perception of pharmacists’ stress level has changed, why do you think it has changed?
"I know more about the responsibilities of pharmacists"
"Before pharmacy school I was not aware of many additional responsibilities of pharmacists outside of
dispensing medications in the community pharmacy setting"
"More exposure to the field, especially exposure to clinical settings "
"personal experience"
"Increased responsibilities with short staffing, pressure to meet company metrics, increased difficulty of
insurance companies."
"My stress level has changed due to the increased intensity of professional school compared to undergrad. I
also believe it has increased because I want to continue to increase my knowledge therefore I take less
healthy mental breaks."
"I have seen how long and hard pharmacists work."
"Understanding of responsibilities "
"I think when you are new it is high but pharmacists that have been practicing for a while are average stress
level"
"growing responsibilities"
"Larger workload"
"the exposure has shown me that pharmacists are often times very stressed."
"Corporate pressure to meet unobtainable goals, reduced staffing, etc."
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"I have learned more about the profession and all the things that go into being a pharmacist."
"I have spoken with more pharmacists about their experiences"
"I guess I didn't realize the breadth of the responsibilities of a pharmacist until I gained more responsibility as
an intern."
"I have been more exposed to a pharmacist's day-to-day work and responsibilities."
"I think it has changed because now I have been able to experience many environments pharmacist work in. I
have experienced stressful days and the many roles and responsibilities."
"Seeing/being around it and getting first hand experience"
"Understaffed, high demand work. Especially in the pandemic"
"Talking to pharmacists at work"
"I think my increased exposure to pharmacists in different settings has opened my eyes to the high level of
stress that pharmacists deal with."
"The lack of understanding from other professionals AND patients."
"Working with more pharmacists outside of independent"
"I have realized since starting rotations that pharmacists have even more to check than I thought."
"Pushing residency"
Q22: Do you have any suggestions or comments related to the QPR training session that you
completed in August 2019?
I think it's such an important training for all healthcare professionals. I could use a good refresher though!
I 100% absolutely would love a refresher and a lecture on the common drugs used for suicide. This is such a
great idea!!
The actual application or "practice" doesn't really happen or stand out to remember easily like CPR lessons.

